14.4 Lipolysis and Lipid Biosynthesis: Fatty Acids, Triacylglycerols, and Cholesterol
Key Takeaways
Adipose lipolysis is switched on by glucagon and adrenaline through cAMP and protein kinase A, which activate hormone-sensitive lipase; insulin opposes it.
Acetyl-CoA carboxylase, a biotin enzyme, makes malonyl-CoA in the committed step of fatty acid synthesis; citrate activates it and palmitoyl-CoA and AMPK phosphorylation inhibit it.
Making one palmitate needs 8 acetyl-CoA, 7 ATP, and 14 NADPH, supplied mainly by the pentose phosphate pathway and malic enzyme.
Humans cannot add double bonds beyond carbon 9 of a fatty acid, so linoleic acid (omega-6) and alpha-linolenic acid (omega-3) are essential in the diet.
HMG-CoA reductase, the rate-limiting enzyme of cholesterol synthesis, converts HMG-CoA to mevalonate using 2 NADPH and is the target of statin drugs.
14.4 Lipolysis and Lipid Biosynthesis: Fatty Acids, Triacylglycerols, and Cholesterol
Quick Answer: Lipid metabolism (area G2, 12 items) lists lipolysis, beta-oxidation, ketone bodies, fatty acid synthesis, triacylglycerol synthesis, and cholesterol synthesis. Section 14.2 covers beta-oxidation and ketone bodies. This section covers the breakdown of stored fat and the three biosynthetic pathways, with their key regulatory enzymes, stoichiometry, and drug targets.
Lipolysis: Mobilizing Stored Fat
Triacylglycerols in adipocytes are hydrolysed in three steps by adipose triglyceride lipase (ATGL), hormone-sensitive lipase (HSL), and monoacylglycerol lipase.
- Fasting and stress hormones (glucagon, adrenaline) activate adenylyl cyclase. cAMP then activates protein kinase A, which phosphorylates HSL and perilipin on the lipid droplet, releasing fatty acids.
- Insulin activates phosphodiesterase, lowering cAMP and stopping lipolysis.
- Free fatty acids travel in blood bound to albumin and are oxidized in muscle, heart, and liver.
- Glycerol goes to the liver, where glycerol kinase phosphorylates it; it is then oxidized to dihydroxyacetone phosphate and enters gluconeogenesis or glycolysis. Adipocytes have little glycerol kinase, so they cannot reuse it.
Fatty Acid Synthesis
Exporting Acetyl-CoA: The Citrate Shuttle
Acetyl-CoA is made in mitochondria, but fatty acid synthesis runs in the cytosol. Citrate carries the acetyl group out:
- Citrate synthase forms citrate in the matrix, and the citrate is exported.
- ATP-citrate lyase in the cytosol splits citrate into acetyl-CoA and oxaloacetate, using ATP.
- Oxaloacetate is reduced to malate, and malic enzyme decarboxylates malate to pyruvate, producing NADPH.
The Committed Step: Acetyl-CoA Carboxylase (ACC)
| Regulator | Effect on ACC |
|---|---|
| Citrate | Activates (promotes polymerization) |
| Palmitoyl-CoA | Inhibits (feedback) |
| AMP-activated protein kinase (low energy) | Phosphorylates and inactivates |
| Insulin | Activates (dephosphorylation) |
| Glucagon, adrenaline | Inactivate |
Malonyl-CoA also inhibits carnitine palmitoyltransferase I, so newly made fatty acids are not sent straight into beta-oxidation.
The Fatty Acid Synthase Cycle
Mammalian fatty acid synthase is a large multifunctional dimer. The growing chain is attached to the phosphopantetheine arm of the acyl carrier protein (ACP). Each turn adds two carbons:
- Condensation (ketoacyl synthase): the acyl group condenses with malonyl-ACP, releasing . The decarboxylation drives the reaction.
- Reduction (ketoacyl reductase) with NADPH gives a D-3-hydroxyacyl group.
- Dehydration (dehydratase) gives a trans-enoyl group.
- Reduction (enoyl reductase) with NADPH gives a saturated acyl group.
After seven cycles, thioesterase releases palmitate (C16).
The 7 ATP are spent by ACC making 7 malonyl-CoA. NADPH comes from the pentose phosphate pathway and malic enzyme.
Synthesis Compared with Beta-Oxidation
| Feature | Fatty Acid Synthesis | Beta-Oxidation |
|---|---|---|
| Location | Cytosol | Mitochondrial matrix |
| Acyl carrier | ACP | Coenzyme A |
| Two-carbon unit | Added from malonyl-CoA | Removed as acetyl-CoA |
| Redox coenzymes | NADPH (reduction) | and (oxidation) |
| 3-Hydroxyacyl isomer | D | L |
| Hormonal signal | Insulin (fed state) | Glucagon, adrenaline (fasting) |
Elongation and Desaturation
Enzymes on the endoplasmic reticulum lengthen palmitate using malonyl-CoA, giving stearate (C18) and longer chains. Desaturases introduce cis double bonds: the delta-9 desaturase converts stearate to oleate. Humans cannot add double bonds beyond carbon 9, so linoleic acid (omega-6) and alpha-linolenic acid (omega-3) are essential. They are precursors of arachidonic acid, eicosanoids, EPA, and DHA.
Triacylglycerol and Phospholipid Synthesis
- Glycerol-3-phosphate comes from dihydroxyacetone phosphate (glycerol-3-phosphate dehydrogenase) or, in liver, from glycerol (glycerol kinase).
- Two acyl-CoAs acylate it, giving phosphatidic acid.
- A phosphatase removes the phosphate, giving diacylglycerol.
- A third acyl-CoA gives triacylglycerol.
Phosphatidic acid and diacylglycerol are branch points for phospholipids: CDP-diacylglycerol leads to phosphatidylinositol, and CDP-choline plus diacylglycerol gives phosphatidylcholine.
Cholesterol Synthesis
All 27 carbons of cholesterol come from acetyl-CoA, 18 acetyl-CoA molecules in total.
| Stage | Key Steps |
|---|---|
| 1. Mevalonate | 2 acetyl-CoA form acetoacetyl-CoA; HMG-CoA synthase adds a third to give HMG-CoA; HMG-CoA reductase (ER, 2 NADPH, rate-limiting) gives mevalonate |
| 2. Isoprene units | Mevalonate is phosphorylated and decarboxylated (3 ATP) to isopentenyl pyrophosphate (C5), which isomerizes to dimethylallyl pyrophosphate |
| 3. Squalene | C5 + C5 gives geranyl pyrophosphate (C10); adding C5 gives farnesyl pyrophosphate (C15); two farnesyl units join head to head as squalene (C30) |
| 4. Cyclization | Squalene epoxide cyclizes to lanosterol, which is converted to cholesterol (C27) |
Regulation of HMG-CoA reductase:
- Sterol feedback through SREBP: low cellular cholesterol releases this transcription factor, which raises HMG-CoA reductase and LDL-receptor expression. High sterol levels also speed degradation of the enzyme.
- Hormones and energy: insulin promotes the active dephosphorylated form, while glucagon and AMPK phosphorylation inactivate it.
- Statins are competitive inhibitors that lower blood LDL cholesterol.
Cholesterol is the precursor of bile acids, steroid hormones (cortisol, aldosterone, sex hormones), and vitamin D.
Lipoproteins
| Lipoprotein | Main Cargo | Route |
|---|---|---|
| Chylomicrons | Dietary triacylglycerol | Intestine to tissues |
| VLDL | Liver-made triacylglycerol | Liver to tissues; becomes IDL and then LDL |
| LDL | Cholesterol | To tissues through LDL receptors ("bad cholesterol") |
| HDL | Cholesterol | Reverse transport from tissues to liver ("good cholesterol") |
How many NADPH molecules are needed to synthesize one palmitate from acetyl-CoA?
14
16
8
7
Which molecule allosterically activates acetyl-CoA carboxylase, signalling that acetyl units and energy are plentiful for fat synthesis?
AMP
Citrate
Palmitoyl-CoA
Glucagon
Statin drugs lower blood cholesterol by inhibiting which enzyme?
Acetyl-CoA carboxylase, which makes malonyl-CoA
HMG-CoA synthase, which forms HMG-CoA in the cytosol
Squalene epoxidase, which prepares squalene for cyclization
HMG-CoA reductase, which converts HMG-CoA to mevalonate
Sections you finish are checked off in the contents.